Inventor
WANG YAOLIN
US27 patents
⚠️ This page may combine multiple inventors who share the name “WANG YAOLIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SCHERING CORP
5 patentsUS7811562B2Oct 12, 2010
Biomarkers for pre-selection of patients for anti-IGF1R therapy
SCHERING CORP7 citations73
US8034907B2Oct 11, 2011
Polynucleotides encoding soluble, stable forms of human double minute 2 polypeptides
SCHERING CORP0 citations49
US7632920B2Dec 15, 2009
Soluble, stable form of HDM2, crystalline forms thereof and methods of use thereof
SCHERING CORP0 citations49
US7888474B2Feb 15, 2011
HDM2 polypeptides
SCHERING CORP0 citations48
US7705127B1Apr 27, 2010
HDM2 Polypeptides
SCHERING CORP0 citations48
WUHAN TIANMA MICRO ELECTRONICS CO LTD
5 patentsUS11699373B2Jul 11, 2023
Display panel and display device with reduced charge accumulation in semiconductor layer
WUHAN TIANMA MICRO ELECTRONICS CO LTD2 citations72
US11374084B2Jun 28, 2022
Organic light emitting display panel and display device
WUHAN TIANMA MICRO ELECTRONICS CO LTD4 citations72
US12094384B2Sep 17, 2024
Display panel and display device with reduced charge accumulation in semiconductor layer
WUHAN TIANMA MICRO ELECTRONICS CO LTD0 citations62
US11900876B2Feb 13, 2024
Display panel, method for driving the same, and display apparatus
WUHAN TIANMA MICRO ELECTRONICS CO LTD0 citations62
US11847960B2Dec 19, 2023
Display panel, method for driving the same, and display apparatus
WUHAN TIANMA MICRO ELECTRONICS CO LTD0 citations62
INVENTISBIO CO LTD
5 patentsUS12391677B2Aug 19, 2025
Thyroid hormone receptor agonists
INVENTISBIO CO LTD0 citations59
US12173010B2Dec 24, 2024
Heterocyclic compounds, preparation methods therefor, and methods of uses thereof
INVENTISBIO CO LTD0 citations57
US12110289B2Oct 8, 2024
Heterocyclic compounds, preparation methods and uses thereof
INVENTISBIO CO LTD0 citations57
US11691981B2Jul 4, 2023
Heterocyclic compounds, preparation methods therefor, and methods of uses thereof
INVENTISBIO CO LTD0 citations57
US12427146B2Sep 30, 2025
C-terminal SRC kinase inhibitors
INVENTISBIO CO LTD0 citations49
INVENTISBIO LLC
3 patentsUS10980807B2Apr 20, 2021
Inhibitor of indoleamine-2,3-dioxygenase (IDO)
INVENTISBIO LLC5 citations70
US12187736B2Jan 7, 2025
Selective estrogen receptor degraders and uses thereof
INVENTISBIO LLC0 citations60
US11969425B2Apr 30, 2024
Inhibitor of indoleamine-2,3-dioxygenase (IDO)
INVENTISBIO LLC0 citations60